EDC Stephen Wisniewski, PhD to Lead NIH Trials in COVID-19 Care

The National Institutes of Health (NIH) has selected the University of Pittsburgh to lead a trio of Phase 3 clinical trials involving COVID-19 patients. Collectively known as ACTIV-4 Antithrombotics, these trials will explore the use of blood thinners in saving lives and improving care, particularly among adult COVID-19 patients who are at risk of developing life-threatening blood clots.

Hormone Therapy Linked to Heart Fat, Hard Arteries

Hormone replacement therapy is a common treatment for menopause-related symptoms, and new research from the University of Pittsburgh Graduate School of Public Health reinforces the importance of tailoring hormone therapy to each patient, based on her individual risk factors for cardiovascular disease.

Those Most at Risk for Weight Regain Post-Bariatric Surgery

“Bariatric surgery is the most effective treatment for severe obesity. It results in sustained weight reduction and remission of diabetes and other health problems in the majority of patients,” said lead author Wendy King, Ph.D., associate professor in Pitt Public Health’s Department of Epidemiology.